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OBJECTIVES The aim of this study was to investigate whether the prognostic importance of left ventricular
(LV) outflow obstruction in hypertrophic cardiomyopathy (HCM) is influenced by other
predictors of morbidity and mortality.
BACKGROUND It remains unknown whether the effect of outflow obstruction on clinical outcome in HCM
is influenced by other determinants of survival.
METHODS We assessed the impact of severity of symptoms, LV wall thickness, atrial fibrillation, and age
on the prognostic importance of outflow obstruction in a large HCM population.
RESULTS Of 526 consecutive HCM patients, 141 (27%) had outflow obstruction. During a follow-up
of 4.5  4.1 years, 34 patients died of HCM. The incidence of cardiovascular death was
significantly higher among patients with LV obstruction than among those without obstruction
(relative risk [RR]  2.14; p  0.02). The prognostic power of the outflow gradient changed in
relation to severity of symptoms (p  0.024). At initial evaluation, LV obstruction was a
significant predictor of cardiovascular mortality only in New York Heart Association (NYHA)
functional class I to II patients (hazard ratio [HR] 2.38; p 0.025). During follow-up, at time
of development of severe symptoms, the outflow gradient lost its prognostic significance (HR 
1.18; p  0.66), whereas NYHA functional class III to IV was associated with an eight-fold
increase in risk of cardiovascular mortality (HR  7.90; p  0.001).
CONCLUSIONS In patients with HCM, the prognostic importance of LV outflow obstruction varies in
relation to the severity of symptoms. In patients with mild or no symptoms, obstruction is an
important predictor of cardiovascular death. After development of severe symptoms, NYHA
functional class becomes the dominant marker of prognosis independently of the presence of
an outflow gradient. (J Am Coll Cardiol 2005;45:1076–80) © 2005 by the American
ublished by Elsevier Inc. doi:10.1016/j.jacc.2004.12.067College of Cardiology Foundation
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eeft ventricular (LV) outflow obstruction is present in 20% to
5% of patients with hypertrophic cardiomyopathy (HCM)
1–3). Despite the frequency of this functional abnormality, its
linical and prognostic implications have remained controver-
ial for more than 30 years (1,2,4–6). Recently, a study
erformed in a large HCM cohort has shown that LV
bstruction is an important predictor of disease progression
nd cardiovascular death (7). However, it remains unclear
hether and to what extent the prognostic power of the
radient is influenced by other determinants of morbidity and
ortality, including severity of symptoms, magnitude of LV
all thickness, and atrial fibrillation (AF). Clarification of the
rognostic importance of LV obstruction in different sub-
roups is also acquiring particular relevance because of the
apidly increasing number of HCM patients undergoing non-
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ccepted December 21, 2004.harmacologic interventions for relief of the outflow gradient
8–10). In the present study, we assessed the effect of LV
utflow obstruction on clinical outcome in a consecutive HCM
opulation including more than 500 patients and, in particular,
e investigated whether the prognostic importance of the
radient is influenced by other predictors of survival.
ETHODS
tudy population. Each of the 543 HCM patients con-
ecutively evaluated at the Ospedali Galliera in Genoa from
une 1983 (329 patients) and at the Università “La Sapi-
nza”, in Rome, from December 1980 (214 patients) were
nitially considered for inclusion in the study. Four patients
ith a single evaluation and 13 with myectomy operation or
lcohol septal ablation before initial evaluation were ex-
luded from the investigation. Therefore, the final study
opulation comprised 526 patients. Follow-up started at
rst evaluation at the two centers. In patients who under-
ent heart transplantation (three patients), myectomy op-
ration (four patients), and alcohol septal ablation (eight
atients), follow-up was terminated at the time of the
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April 5, 2005:1076–80 Hypertrophic Cardiomyopathy, Outflow Obstructionrocedure. None of the 19 patients with a cardioverter-
efibrillator experienced ventricular fibrillation. No patient
eceived a pacemaker to reduce the gradient.
efinitions. The diagnosis of HCM was based on echo-
ardiographic criteria previously described (11). Sudden
ardiac death, heart failure or stroke-related death, and family
istory of sudden death were defined as previously reported
11–14). Left ventricular wall thickness, cavity dimension, and
eft atrial size were assessed using echocardiographic criteria
reviously described (11,12). Outflow obstruction under basal
onditions was considered present when a peak gradient 30
m Hg was identified by Doppler echocardiography (7,11–
4). Echocardiographic measurements were obtained by a
ingle investigator in each of the patients evaluated in Genoa
P.S.) and in Rome (C.A.).
tatistical methods. Mortality rates were estimated by
ividing the number of deaths by the number of person-
ears accumulated during follow-up. For calculation of rates
f each cause-specific mortality, patients who died from
ther causes were censored as alive at time of death. Rates
ere compared using the chi-square test for heterogeneity;
he chi-square test for trend was used for ordinary variables,
nd the Fisher exact test was used when events were5. To
ssess LV obstruction role as an independent predictor of
ardiovascular mortality, a multivariate Cox proportional
azard model was fitted to the data, and the following
ariables were included: age, gender, New York Heart
Abbreviations and Acronyms
AF  atrial fibrillation
CI  confidence interval
HCM  hypertrophic cardiomyopathy
HR  hazard ratio
LV  left ventricular
NYHA  New York Heart Association
able 1. Baseline Characteristics in the Overall Study HCM Pop
utflow Obstruction
Variable
Overall HCM
Population
umber of patients 526
ge (yrs), mean (median) 47 (49)
ale gender, no. (%) 343 (65)
amily history of sudden death, no. (%) 115 (22)
YHA functional class III or IV, no. (%) 40 (8)
trial fibrillation,* no. (%) 86 (16)
aximal LV wall thickness (mm) 20  5
V end-diastolic cavity dimension (mm) 46  5
eft atrial dimension (mm) 44  7
reatment, no. (%)
None 186 (35)
Beta-blockers 158 (30)
Calcium antagonists 164 (31)
Amiodarone 43 (8)
Diuretics 77 (15)Either paroxysmal or chronic.
HCM  hypertrophic cardiomyopathy; LV  left ventricular; NYHA  New York Hssociation (NYHA) functional class I to II or III to IV,
bstruction, sudden-death family history, AF, LV maximal
all thickness, cavity dimension, and left atrial size. Vari-
bles not significantly associated with outcome were re-
oved from the model using a step-down procedure based
n the likelihood-ratio test.
The modifying effect (interaction) that the variables
etained in the final model could have on the obstruction
rognostic power was assessed by introducing in the model,
ne at a time, the appropriate interaction terms, and by
valuating the change in the likelihood of the model. To
urther explore the combined effect of NYHA functional
lass and obstruction on mortality, the term denoting func-
ional class was removed from the model and replaced by a
ime-dependent covariate indicating class at each point in time.
he NYHA functional class I to II patients were assigned a 0
alue until deterioration to class III to IV, and 1 thereafter. The
YHA functional class III to IV patients at initial evaluation
ere assigned a 1 value for the entire follow-up. An interaction
erm between obstruction and the time-dependent covariate
as also included in the model to assess the effect of obstruc-
ion on cardiovascular mortality after progression to NYHA
unctional class III to IV. All p values are two-sided.
ESULTS
V obstruction and prognosis. Of the 526 study patients,
41 (27%) had LV obstruction. Baseline characteristics are
ummarized in Table 1. Mean follow-up was 4.5  4.1
ears and was similar in patients with and without obstruc-
ion (mean 4.4  4.3 years and 4.5  4.1 years, respec-
ively). During follow-up, 49 (9%) patients died: 15 (31%)
f noncardiac causes, and 34 (69%) of cardiovascular causes,
f whom 15 (44%) died suddenly, 10 (30%) died of heart
ailure, and 9 (26%) died of stroke. Mortality due to stroke
ppeared to contribute importantly to the excess in cardio-
on, and in Patients With and Without LV
Patients With LV
utflow Obstruction
Patients Without LV
Outflow Obstruction p Value
141 385
49 (50) 47 (48) 0.194
79 (56) 264 (69) 0.01
25 (18) 90 (23) 0.191
18 (13) 22 (6) 0.009
23 (16) 63 (16) 0.989
22  4 19  5 0.001
45  5 46  5 0.001
47  6 43  7 0.001
24 (17) 162 (42) 0.001
63 (45) 95 (25) 0.001
58 (41) 106 (27) 0.004
11 (8) 32 (8) 0.9
31 (22) 46 (12) 0.006ulati
Oeart Association.
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Hypertrophic Cardiomyopathy, Outflow Obstruction April 5, 2005:1076–80ascular mortality in patients with obstruction (relative risk
RR] 3.44, 95% confidence interval [CI] 0.92 to 12.81; p 
.06). Incidence of cardiovascular death, severe heart failure,
r AF was significantly higher in patients with obstruction
Table 2). At 10-year follow-up, cumulative risk of cardio-
ascular death, severe heart failure, or AF were, respectively,
7%, 34%, and 43% in patients with obstruction, and 9%,
5%, and 18% in those without obstruction (Figs. 1 to 3).
Analysis of mortality rates in patients with a different
agnitude of outflow gradient (30 to 60 mm Hg in 73
atients, and 60 mm Hg in 68 patients) did not show any
ncrease in the risk of cardiovascular death with increasing
evel of obstruction, with the incidence per 100 patient-
ears being 2.68% (95% CI 1.28 to 4.93) and 2.51% (95%
I 0.81 to 5.86), respectively, in the two groups.
nivariate and multivariate analyses. The results of the
nivariate and multivariate analyses are summarized in
able 3. In particular, in the multivariate model, outflow
bstruction was associated with a 68% increase in cardio-
ascular death (hazard ratio [HR] 1.68, 95% CI 0.83 to
.40), age showed borderline significance (p  0.07), and
all thickness, NYHA functional class III to IV, and AF
ere strongly associated with cardiovascular mortality.
Of the 15 patients who died suddenly, 5 (33%) had
xtreme LV hypertrophy (maximal wall thickness 30
m). At multivariate analysis, extreme wall thickness
howed a strong association with sudden death (HR 6.99,
5% CI 2.37 to 20.65; p  0.0001).
able 2. Incidence of Cardiac Death, Development of Severe He
atients With or Without LV Outflow Obstruction
Outcome
Patients With LV
Obstruction
No. of
Patients
(%)
Incidenc
Perso
(95%
ardiovascular death 15 (10.6) 2.40 (1.
rogression to NYHA functional class III to IV 24 (20.0) 4.44 (2.
trial fibrillation* 24 (20.0) 4.45 (2.
Either paroxysmal or chronic.
CI  confidence interval; other abbreviations as in Table 1.
igure 1. Kaplan-Meier estimates of the proportion of patients with or
I
(
ithout left ventricular obstruction who died of cardiovascular causes, among
he overall 526 hypertrophic cardiomyopathy (HCM) study patients.rognostic interaction between LV obstruction and other
linical features. In a multivariate Cox model, the appro-
riate interaction terms were introduced to assess whether
he prognostic implications of LV obstruction were either
ore marked, or exclusively present in particular patient
ubgroups. Age, wall thickness, and AF did not modify the
rognostic power of obstruction (test for interaction p 
.80, p  0.92, and p  0.91, respectively) (Table 4).
onversely, a highly significant interaction was identified
etween prognostic power of obstruction and NYHA func-
ional class at initial evaluation (p 0.024). As a consequence
f this interaction, LV obstruction remained a significant
redictor of cardiovascular mortality only in patients in NYHA
unctional class I to II (HR  2.38; p  0.025).
The combined effect of LV obstruction and functional
lass on cardiovascular mortality was further evaluated by
ssessing the prognostic significance of obstruction after
rogression to NYHA functional class III to IV during
ollow-up. In patients who developed severe symptoms,
bstruction lost any prognostic significance (HR  1.18;
 0.66), whereas NYHA functional class III to IV was
ssociated with an eight-fold increase in risk of cardiovas-
ular mortality (HR  7.90; p  0.001) (Table 4). The
imited number of events precluded the application of these
nalyses to specific modes of cardiovascular death (heart
ailure, stroke, or sudden death).
igure 2. Kaplan-Meier estimates of the proportion of patients who
rogressed to New York Heart Association (NYHA) functional class (FC)
ailure, or Atrial Fibrillation During Follow-Up in HCM
ow Patients Without LV
Outflow Obstruction
Relative Risk
(95% CI) p Value
100
s
No. of
Patients
(%)
Incidence per 100
Person-Yrs
(95% CI)
96) 19 (4.9) 1.11 (0.66–1.73) 2.14 (1.10–4.20) 0.02
60) 30 (8.0) 1.87 (1.26–2.68) 2.40 (1.34–4.18) 0.002
62) 25 (8.0) 1.71 (1.11–2.52) 2.60 (1.44–4.61) 0.001art F
Outfl
e per
n-Yr
CI)
34–3.
84–6.
85–6.II to IV, among the 486 patients with hypertrophic cardiomyopathy
HCM) in FC I or II at initial evaluation.
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April 5, 2005:1076–80 Hypertrophic Cardiomyopathy, Outflow ObstructionISCUSSION
ur results confirm recent observations indicating that LV
utflow obstruction is associated with an increased risk of
rogression to severe heart failure, AF, and cardiovascular
eath in patients with HCM (7). Our findings, however,
how that the prognostic importance of outflow obstruction
aries in relation to the severity of symptoms. At initial
valuation, LV obstruction was a significant predictor of
rognosis only in patients with mild or no symptoms of
eart failure (HR  2.38), whereas it showed no predictive
ignificance in patients in NYHA functional class III to IV.
We also evaluated the potential variations in the prog-
ostic importance of LV obstruction in relation to progres-
ion of symptoms during follow-up. After development of
evere heart failure, the outflow gradient lost its predictive
ignificance, whereas NYHA functional class III or IV
cquired a strong prognostic power associated with an
ight-fold increase in risk of cardiovascular mortality. The
esults of this latter analysis suggest that outflow obstruction
xerts its negative prognostic effect by favoring progression
o severe functional limitation. Our analysis also showed
hat the prognostic power of obstruction is not influenced by
igure 3. Kaplan-Meier estimates of the proportion of patients with or
ithout left ventricular obstruction who developed either paroxysmal or
hronic atrial fibrillation (AF), among the 440 hypertrophic cardiomyop-
thy (HCM) patients without AF at initial evaluation.
Table 3. Univariate and Multivariate Relation
Clinical Variables*
Variable
Univariate An
p Value†
Age 0.035
NYHA functional class (III to IV) 0.0001
LV outflow obstruction 0.022
Atrial fibrillation 0.0001
LV wall thickness (mm) 0.004
LV diastolic diameter (mm) 0.634
Left atrial size (mm) 0.0001
Gender 0.099
Family history of sudden death 0.422
*The subgroups for each variable were as follows: age was gro
York Heart Association functional class was grouped in two
classes,15, 15 to 19, 20 to 24, 25 to 29, and30 mm. †Est
included one at a time. §Estimated from the final Cox mo
likelihood ratio test, starting from the initial model in which all co
Abbreviations as in Tables 1 and 2.ther features known as markers of morbidity and mortality
n HCM, including AF, wall thickness, and age.
linical implications of findings. Myectomy operation or
lcohol septal ablation by relieving the outflow gradient and
sually associated mitral regurgitation decrease wall stress,
yocardial ischemia, and left atrial size, andmay lessen the risk
f AF and stroke (1–3,8–10,15). At present, definitive evi-
ence is lacking that such interventions prolong survival.
herefore, these procedures are principally recommended to
mprove quality of life in patients with severe symptoms,
nresponsive to medical treatment (1–3,16). However, recent
etrospective studies performed in large HCM populations
uggest that surgery (myectomy operation) may reduce mor-
ality (10,17).
In light of these recent surgical data, our findings that
utflow obstruction loses its prognostic importance after
evelopment of severe heart failure raise the question of
hether a more aggressive approach should be adopted in
elected patients with obstructive HCM, without waiting
or development of severe symptoms. An important diffi-
ulty would come from uncertainties regarding the appro-
riate candidates for early surgical intervention. A potential
riterion could be the co-existence of all those clinical
eatures considered most unfavorable for the long-term
utcome of patients with obstructive HCM, including a
oung age, an outflow gradient under basal conditions,
mportant mitral regurgitation, and a progressively dilating
eft atrium (1–3). However, the risks associated with septal
yectomy (although low at centers with particular experi-
nce with this operation) impose caution, and additional
vidence on the long-term outcome of surgery in patients
ith less severe symptoms is required before this treatment
trategy can be generally adopted.
dditional observations. The cumulative risk of AF at 10
ears after initial evaluation was more than two times higher
n patients with LV obstruction. A clear trend was also
dentified toward an increased rate of death due to stroke in
een Cardiovascular Mortality and Baseline
Multivariate Analysis
p Value§
Multivariate Analysis
Hazard Ratio
(95% CI)
0.074 1.02 (1.00–1.04)
0.022 3.07 (1.17–8.05)
0.146 1.68 (0.83–3.40)
0.001 4.33 (1.94–9.64)
0.001 1.12 (1.05–1.20)
0.93 ‡
0.61 ‡
0.49 ‡
0.80 ‡
n four classes, 20, 20 to 39, 40 to 59, and 60 years. New
s: I to II vs III to IV. Wall thickness was grouped in four
from a Cox model in which the covariates were individually
tained by means of a step-down procedure, based on theBetw
alysis
uped i
classe
imated
del obvariates were included. ‡Excluded from the final model.
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Hypertrophic Cardiomyopathy, Outflow Obstruction April 5, 2005:1076–80atients with a gradient. These findings confirm previous
bservations suggesting that obstruction favors a cascade of
omplications, including left atrial dilatation, AF, and
mbolic stroke (12,18). In addition, in agreement with
revious studies, magnitude of LV hypertrophy was inde-
endently and directly related to cardiovascular mortality
11,19). In particular, extreme wall thickness (30 mm) was
ssociated with a more than five-fold increase in sudden
eath risk.
onclusions. Our results show that the prognostic impor-
ance of LV outflow obstruction in HCM is strongly
nfluenced by the severity of symptoms of heart failure. In
atients with mild or no symptoms, outflow obstruction is a
redictor of cardiovascular death. However, after develop-
ent of severe symptoms, NYHA functional class becomes
he dominant marker of prognosis, independent of the
resence or absence of a gradient. These findings, together
ith recent observations suggesting that myectomy opera-
ion prolongs survival, raise the question of whether surgery
hould be performed in selected patients with outflow
bstruction, without waiting for the development of severe
ymptoms. Additional data on the risk-versus-benefit ratio
re required, however, before this novel approach can
ecome a generally accepted strategy.
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